INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

78,613 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
39.7K sh
Apr 2, 2026Apr 3, 2026
Page 1235 of 1966
← PrevNext →
traded Apr 2, 2026
+1d
SEC Form 4

Evidence

0
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
4,464 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
207 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
782 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
552 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
552 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KJun 15, 2025Apr 2, 2026
traded Jun 15, 2025
+291dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KMar 15, 2025Apr 2, 2026
traded Mar 15, 2025
+383dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KJan 20, 2026Apr 2, 2026
traded Jan 20, 2026
+72dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$500K – $1.00MJan 20, 2025Apr 2, 2026
traded Jan 20, 2025
+437dHouse PTR

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

45
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$100K – $250KSep 15, 2025Apr 2, 2026
traded Sep 15, 2025
+199dHouse PTR

Evidence

45
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$50K – $100KOct 15, 2025Apr 2, 2026
traded Oct 15, 2025
+169dHouse PTR

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

43
Kelly MorrisonDSelf
FLFluxAI
Purchase
BUY$15K – $50KDec 22, 2025Apr 2, 2026
traded Dec 22, 2025
+101dHouse PTR

Evidence

39
Kelly MorrisonDSelf
CACavall
Purchase
BUY$1,001 – $15KDec 22, 2025Apr 2, 2026
traded Dec 22, 2025
+101dHouse PTR

Evidence

30
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$100K – $250KMar 15, 2026Apr 2, 2026
traded Mar 15, 2026
+18dHouse PTR

Evidence

30
AF
Achille John FrankPresident and COO
BLDQXO Insulation, LLC
Grant or award
A$1.15M
3,116 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

28
Kelly MorrisonDSelf
STStarCloud
Purchase
BUY$15K – $50KMar 15, 2026Apr 2, 2026
traded Mar 15, 2026
+18dHouse PTR

Evidence

27
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

27
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

27
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

26
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
11.4K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

26
MM
Mindlin Damian MiguelVice President
PAMPampa Energy Inc.
Open-market sale
SELL$1.78M
500.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

26
David J. TaylorRSelf
KRKROGER CO
Sale
SELL$1,001 – $15KMar 24, 2026Apr 2, 2026
traded Mar 24, 2026
+9dHouse PTR

Evidence

24
PE
Perros EvangelosChief Financial Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$147K
13.0K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

24
HJ
Hsu JenniferChief Financial Officer
YOUClear Secure, Inc.
Tax withholding
F$193K
3,930 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

24
SL
Salmon Taryn LVice Chair
BOHBANK OF HAWAII CORP
Tax withholding
F$241K
3,244 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

24
HT
Howes Brad TEVP, CHIEF FINANCIAL OFFICER
NPBNORTHPOINTE BANCSHARES INC
Option exercise
M$121K
7,000 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

24
DM
Dorsey MarkChief Revenue Officer
APPNAPPIAN CORP
Grant or award
A—
18.1K sh
Aug 20, 2025Apr 2, 2026
traded Aug 20, 2025
+225dSEC Form 4

Evidence

23
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
3,348 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
RV
Raghunathan VivekSVP, Engineering
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$592K
3,876 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.90M
49.3K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

21
FS
Fallan ScottSVP & President, International
GPKGRAPHIC PACKAGING HOLDING CO
Option exercise
M—
1,258 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

21
KE
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Grant or award
A—
21.5K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

21
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
12 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

21
JI
Jerrard Ross IanChief Financial Officer
CMCLCaledonia Mining Corp Plc
Option exercise
M$47K
2,062 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence